Loading...
Back to narrative

MBRF3: Outlook Will Balance Improved Profit Margins With Sustainability Developments

Update shared on 16 Nov 2025

Fair value Decreased 0.47%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-2.9%
7D
-11.7%

Analysts have slightly reduced their price target for Marfrig Global Foods from $24.57 to $24.45. They cite lower projected revenue growth; however, profit margin expectations have improved.

What's in the News

  • Marfrig Global Foods S.A. has been added to the Brazil Corporate Sustainability Index (Key Developments).
  • Marfrig Global Foods S.A. has joined the Brazil Mid-Large Cap Index (Key Developments).
  • Marfrig Global Foods S.A. has been removed from the Brazil Small Cap Index (Key Developments).

Valuation Changes

  • Consensus Analyst Price Target has decreased slightly from R$24.57 to R$24.45.
  • Discount Rate has fallen significantly from 22.33% to 19.39%.
  • Revenue Growth projection has reduced modestly from 3.69% to 3.28%.
  • Net Profit Margin expectation has increased noticeably from 0.50% to 0.73%.
  • Future P/E ratio forecast has risen substantially from 35.18x to 55.64x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.